Highly active antiretroviral therapy in a SCID mouse model of HIV-encephalitis reduces neuropathology and viral load

被引：0
|
作者：
Tyor, WR
Cook, JE
Griffin, WC
Middaugh, LD
机构：
来源：
NEUROLOGY | 2004年 / 62卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A409 / A410
页数：2
相关论文
共 50 条
  • [21] HIV-related neuropathology, 1985 to 1999: Rising prevalence of HIV encephalopathy in the era of highly active antiretroviral therapy
    Neuenburg, JK
    Brodt, HR
    Herndier, BG
    Bickel, M
    Bacchetti, P
    Price, RW
    Grant, RM
    Schlote, W
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 31 (02) : 171 - 177
  • [22] Undetectable HIV-1 viral load in the fluid of bullous skin lesion in a patient receiving highly active antiretroviral therapy
    Tattevin, Pierre
    Maillard, Anne
    Tribut, Olivier
    Saikali, Emilie
    Arvieux, Cedric
    Michelet, Christian
    INTERNATIONAL JOURNAL OF STD & AIDS, 2008, 19 (05) : 357 - 358
  • [23] Rapid viral load suppression following generic highly active antiretroviral therapy in Southern Indian HIV-infected patients
    Kumarasamy, N
    Vallabhaneni, S
    Flanigan, TP
    Balakrishnan, P
    Cecelia, A
    Carpenter, CCJ
    Solomon, S
    Mayer, KH
    AIDS, 2005, 19 (06) : 625 - 627
  • [24] Time to undetectable viral load after highly active antiretroviral therapy initiation among HIV-infected pregnant women
    Patel, Deven
    CLINICAL INFECTIOUS DISEASES, 2007, 44 (12) : 1647 - 1656
  • [25] Highly active antiretroviral therapy and human immunodeficiency virus encephalitis
    Cook, JE
    Dasgupta, S
    Middaugh, LD
    Terry, EC
    Gorry, PR
    Wesselingh, SL
    Tyor, WR
    ANNALS OF NEUROLOGY, 2005, 57 (06) : 795 - 803
  • [26] Raised viral load in patients with viral suppression on highly active antiretroviral therapy: transient increase or treatment failure?
    Moore, AL
    Youle, M
    Lipman, M
    Cozzi-Lepri, A
    Lampe, F
    Madge, S
    Nesaratnam, S
    Tyrer, M
    Cuthbertson, Z
    Ransom, D
    Loveday, C
    Johnson, MA
    Phillips, AN
    AIDS, 2002, 16 (04) : 615 - 618
  • [27] Viral load and CD4+lymphocyte count in the highly active antiretroviral therapy era
    Martín, JC
    Fernández, P
    Soriano, V
    Martínez, P
    González-Lahoz, J
    MEDICINA CLINICA, 2000, 115 (03): : 118 - 118
  • [28] Effect of highly active antiretroviral therapy on viral burden in the lungs of HIV-infected subjects
    Twigg, Homer L., III
    Weiden, Michael
    Valentine, Fred
    Schnizlein-Bick, Carol T.
    Bassett, Roland
    Zheng, Lu
    Wheat, Joseph
    Day, Richard B.
    Rominger, Helen
    Collman, Ronald G.
    Fox, Lawrence
    Brizz, Barbara
    Dragavon, Joan
    Coombs, Robert W.
    Bucy, R. Pat
    JOURNAL OF INFECTIOUS DISEASES, 2008, 197 (01): : 109 - 116
  • [29] Viral reservoirs, residual viremia, and the potential of highly active antiretroviral therapy to eradicate HIV infection
    Shen, Lin
    Siliciano, Robert F.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 122 (01) : 22 - 28
  • [30] Visceral leishmaniasis in HIV-infected patients with non-detectable HIV-1 viral load after highly active antiretroviral therapy
    Jiménez-Expósito, MJ
    Alonso-Villaverde, C
    Sardà, P
    Masana, L
    AIDS, 1999, 13 (01) : 152 - 153
12345